Mezzion Pharma Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was KRW 2,498.11 million compared to KRW 4,204.8 million a year ago. Basic loss per share from continuing operations was KRW 93 compared to KRW 157 a year ago.

Diluted loss per share from continuing operations was KRW 93 compared to KRW 157 a year ago. Basic loss per share was KRW 93 compared to KRW 157 a year ago.